FDA NDC Directory · JSON-LD · Markdown

Budesonide

NDC 0591-2510 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205457
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsBUDESONIDE (9 mg/1)
Marketing started20180705
Package count1

External sources

Source: openFDA. Public-domain (CC0).